We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
-0.87%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$46.4B
AUM Growth
+$701M
(+1.5%)
Cap. Flow
+$2.34B
Cap. Flow
% of AUM
5.06%
Top 10 Holdings %
Top 10 Hldgs %
14.53%
Holding
2,237
New
170
Increased
888
Reduced
909
Closed
187
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$197M |
| 2 |
Deckers Outdoor
DECK
|
+$179M |
| 3 |
DexCom
DXCM
|
+$156M |
| 4 |
Teradyne
TER
|
+$154M |
| 5 |
ExxonMobil
XOM
|
+$153M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$163M |
| 2 |
Wingstop
WING
|
+$130M |
| 3 |
ServiceNow
NOW
|
+$108M |
| 4 |
GoDaddy
GDDY
|
+$94.2M |
| 5 |
Vertiv
VRT
|
+$80M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.5% |
| 2 | Healthcare | 16.86% |
| 3 | Financials | 13.55% |
| 4 | Consumer Discretionary | 9.41% |
| 5 | Industrials | 9.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Fortive
FTV
$16.7B
| $2.85M | 0.01% |
51,628
+7,235
| +16% | +$425K |
|
|
NVEE
852
DELISTED
NV5 Global
NVEE
| $2.84M | 0.01% |
147,605
+53,723
| +57% | +$984K |
|
853
HDFC Bank
HDB
$115B
| $2.84M | 0.01% |
85,360
-18,458
| -18% | -$563K |
|
854
Hims & Hers Health
HIMS
$6.53B
| $2.83M | 0.01% |
95,827
-85,235
| -47% | -$3.17M |
|
855
Markel Group
MKL
$22.1B
| $2.81M | 0.01% |
1,504
-14
| -0.9% | -$25.8K |
|
856
Tarsus Pharmaceuticals
TARS
$3.63B
| $2.81M | 0.01% |
54,682
-23,032
| -30% | -$1.14M |
|
857
Veracyte
VCYT
$3.1B
| $2.8M | 0.01% |
94,423
-27,590
| -23% | -$1.05M |
|
858
Sylvamo
SLVM
$1.43B
| $2.79M | 0.01% |
41,579
-9,685
| -19% | -$706K |
|
859
Jones Lang LaSalle
JLL
$15.7B
| $2.78M | 0.01% |
11,222
+5,415
| +93% | +$1.42M |
|
860
Independence Realty Trust
IRT
$3.52B
| $2.78M | 0.01% |
131,001
+42,975
| +49% | +$865K |
|
861
Rocket Pharmaceuticals
RCKT
$382M
| $2.76M | 0.01% |
+414,497
| New | +$4.1M |
|
862
SCYNEXIS
SCYX
$40.9M
| $2.76M | 0.01% |
361,875
| – | – |
|
863
Glaukos
GKOS
$9.64B
| $2.72M | 0.01% |
27,609
-615
| -2% | -$82K |
|
864
Take-Two Interactive
TTWO
$39.6B
| $2.71M | 0.01% |
13,097
-4,883
| -27% | -$976K |
|
865
Roper Technologies
ROP
$37.2B
| $2.71M | 0.01% |
4,600
-821
| -15% | -$461K |
|
866
InMode
INMD
$839M
| $2.7M | 0.01% |
152,430
+14,203
| +10% | +$256K |
|
867
Warby Parker
WRBY
$2.91B
| $2.7M | 0.01% |
148,098
-2,999
| -2% | -$71.6K |
|
868
Ardmore Shipping
ASC
$779M
| $2.69M | 0.01% |
275,062
-185,763
| -40% | -$2.03M |
|
|
SNCY
869
DELISTED
Sun Country Airlines
SNCY
| $2.69M | 0.01% |
218,180
+24,942
| +13% | +$386K |
|
870
East-West Bancorp
EWBC
$17.3B
| $2.68M | 0.01% |
29,862
+5,485
| +23% | +$523K |
|
871
GE HealthCare
GEHC
$28.7B
| $2.67M | 0.01% |
33,114
-38,619
| -54% | -$3.32M |
|
872
Interface
TILE
$2B
| $2.66M | 0.01% |
134,243
+27,109
| +25% | +$591K |
|
873
Alkermes
ALKS
$7.73B
| $2.63M | 0.01% |
79,590
-274,659
| -78% | -$8.96M |
|
|
FLCV
874
Federated Hermes MDT Large Cap Value ETF
FLCV
$146M
| $2.62M | 0.01% |
95,004
+4
| +0% | +$112 |
|
875
Fluence Energy
FLNC
$1.3B
| $2.62M | 0.01% |
541,168
+519,601
| +2,409% | +$4.97M |
|
Similar funds
Federated Hermes's Q1 2025 Portfolio in Review
As of Q1 2025, Federated Hermes held 2,237 positions worth $46.4B, up 1.5% from $45.7B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.34B of net new capital in Q1 2025, opening 170 new positions and adding to 888 existing holdings. Its largest new stake was Zscaler: 283,095 shares worth $56.2M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Gilead Sciences, an estimated $163M trimmed.
- Federated Hermes's largest Q1 2025 buy was Zscaler: 283,095 shares worth $56.2M.
- Federated Hermes added most to Amgen in Q1 2025, an estimated $197M increase.
- Federated Hermes's biggest Q1 2025 reduction was Gilead Sciences, cutting an estimated $163M.
- Federated Hermes fully exited New Fortress Energy in Q1 2025, selling an estimated $31.4M.
- Federated Hermes's ten largest holdings make up 15% of its $46.4B portfolio in Q1 2025.
- Federated Hermes opened 170 new positions and closed 187 in Q1 2025.
- Federated Hermes's portfolio value rose 1.5% quarter-over-quarter to $46.4B.
Based on Federated Hermes's 13F filing for Q1 2025, filed 8 May 2025.